Related Experiment Videos
Equine cell-mediated immune response to Rhodococcus (Corynebacterium) equi
American Journal of Veterinary Research
|November 1, 1984
Summary
A new lymphocyte blastogenic assay effectively measures cell-mediated immunity to Rhodococcus equi (R equi) in horses. This assay shows inoculated horses develop immune responses, aiding in understanding equine R equi infections.
Area of Science:
- Veterinary Immunology
- Equine Infectious Diseases
Background:
- Rhodococcus equi (R equi) causes significant respiratory disease in foals.
- Assessing cell-mediated immunity (CMI) is crucial for understanding equine immune responses to R equi.
- Existing methods for evaluating CMI in horses against R equi are limited.
Purpose of the Study:
- To develop and validate a lymphocyte blastogenic assay as an in vitro correlate of CMI to R equi in equines.
- To investigate the development of CMI following experimental R equi inoculation.
- To assess CMI responses in horses from herds with endemic R equi infections.
Main Methods:
- Development of a lymphocyte blastogenic assay using R equi heat and lysozyme extracts.
- Experimental inoculation of ponies with live R equi via subcutaneous, intranasal, and intratracheal routes.
- Performance of blastogenesis assays and delayed-type hypersensitivity tests on experimental and field-collected samples.
Main Results:
- Lymphocytes from experimentally inoculated ponies demonstrated a mitogenic response to R equi antigens post-inoculation.
- Non-inoculated control ponies showed no lymphocyte response to R equi antigens.
- Delayed-type hypersensitivity reactions were observed in all experimentally exposed ponies.
- Blastogenesis assays on horses from endemic herds revealed significant cell-mediated responses, but without clear correlation to clinical history.
Conclusions:
- The developed lymphocyte blastogenic assay is a viable tool for assessing CMI to R equi in equines.
- Cell-mediated immunity plays a role in the equine immune system's interaction with R equi.
- Further research is needed to correlate CMI responses with clinical outcomes in naturally infected herds.